Camlin Fine Sciences Ltd
Fundamental Score
Camlin Fine Sciences Ltd Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of CAMLINFINE across key market metrics for learning purposes.
Positive Indicators
0 factors identified
No significant strengths identified in current analysis.
Risk Factors
10 factors identified
Below-Average Return on Equity (-14.97%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Premium Valuation Risk (P/E: 189.68x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations. Consider entry timing carefully.
Profit Decline Concern (-115.76%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes. Monitor for recovery signs and management guidance.
Weak Interest Coverage (1.48x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability. Monitor cash flow and debt reduction plans.
Negative Free Cash Flow (₹-64.04 Cr over 5Y)
Observation: Cash outflows exceed inflows, indicating capital intensity or working capital issues.
Analysis: Negative FCF requires analysis of capital expenditure cycle and working capital management efficiency.
Limited Institutional Interest (FII+DII: 7.59%)
Observation: Low institutional participation may affect liquidity and visibility.
Analysis: Limited institutional interest may indicate size constraints or visibility issues in the investment community.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.
Very Low ROE
Observation: Poor capital utilization and shareholder returns.
Analysis: ROE below 5% suggests significant inefficiencies in capital deployment.
High P/E Ratio
Observation: Stock may be overvalued relative to earnings.
Analysis: P/E above 30 requires strong growth execution to justify current valuations.
Very High P/E Ratio
Observation: Significant overvaluation risk present.
Analysis: Extremely high P/E ratios indicate potential bubble territory and high downside risk.
Financial Statements
Comprehensive financial data for Camlin Fine Sciences Ltd
About CAMLINFINE
Business Overview
Camlin Fine Sciences Limited, together with its subsidiaries, research, develops, manufactures, and markets specialty chemicals, ingredients, and additive blend products in India and internationally. The company offers shelf-life solutions, which include basic ingredients, such as tert-butylhydroquinone (TBHQ), Butylated Hydroxyanisole (BHA), Butylated Hydroxytoluene (BHT), and Ascorbyl Palmitate (ASP); aroma ingredients, including vanillin and ethyl vanillin, natural vanillin, and some of its combinations; performance chemicals that include Hydroquinone (HQ), Catechol (CAT), Monomethyl Ether of HQ (MEHQ), tert butylcatechol (TBC), Guaiacol, and Veratrole; and health and wellness products comprising algae based products, such as Omega 3 fatty acids. It sells its prodycrts under the Xtendra, Nasure, Ezential, adorr, Dinamic, and Biosus brands. The company's products are used in food and beverage, pet food and rendering, animal nutrition, petrochemical, nutrition and health, biofuel, agrochemical, pharmaceutical, polymers, fragrance and flavor, and dyes and pigments industries. The company was formerly known as Camlin Fine Chemicals Ltd. and changed its name to Camlin Fine Sciences Limited in August 2011. Camlin Fine Sciences Limited was founded in 1931 and is headquartered in Mumbai, India.
Company Details
Key Leadership
Corporate Events
CAMLINFINE Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Camlin Fine Sciences Ltd (CAMLINFINE)?
As of 21 Jan 2026, 08:48 am IST, Camlin Fine Sciences Ltd (CAMLINFINE) is currently trading at ₹136.92. The stock has a market capitalization of ₹3.05K (Cr).
Is CAMLINFINE share price Overvalued or Undervalued?
CAMLINFINE is currently trading at a P/E ratio of 189.68x, compared to the industry average of 29.20x. Based on this relative valuation, the stock appears to be Overvalued against its sector peers.
What factors affect the Camlin Fine Sciences Ltd share price?
Key factors influencing CAMLINFINE's price include its quarterly earnings growth (Sales Growth: 10.19%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Camlin Fine Sciences Ltd a good stock for long-term investment?
Camlin Fine Sciences Ltd shows a 5-year Profit Growth of N/A% and an ROE of -14.97%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.76 before investing.
How does Camlin Fine Sciences Ltd compare with its industry peers?
Camlin Fine Sciences Ltd competes with major peers in the Specialty Chemicals. Investors should compare CAMLINFINE's P/E of 189.68x and ROE of -14.97% against the industry averages to determine its competitive standing.
What is the P/E ratio of CAMLINFINE and what does it mean?
CAMLINFINE has a P/E ratio of 189.68x compared to the industry average of 29.20x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹190 for every ₹1 of annual earnings.
How is CAMLINFINE performing according to Bull Run's analysis?
CAMLINFINE has a Bull Run fundamental score of 4.6/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does CAMLINFINE belong to?
CAMLINFINE operates in the Specialty Chemicals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Camlin Fine Sciences Ltd.
What is Return on Equity (ROE) and why is it important for CAMLINFINE?
CAMLINFINE has an ROE of -14.97%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently Camlin Fine Sciences Ltd generates profits from shareholders' equity.
How is CAMLINFINE's debt-to-equity ratio and what does it indicate?
CAMLINFINE has a debt-to-equity ratio of 0.76, which indicates moderate leverage that should be monitored. A ratio below 1.0 generally indicates conservative financing.
What is CAMLINFINE's dividend yield and is it a good dividend stock?
CAMLINFINE offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.
How has CAMLINFINE grown over the past 5 years?
CAMLINFINE has achieved 5-year growth rates of: Sales Growth 9.70%, Profit Growth N/A%, and EPS Growth N/A%.
What is the promoter holding in CAMLINFINE and why does it matter?
Promoters hold 49.08% of CAMLINFINE shares, with 10.84% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is CAMLINFINE's market capitalization category?
CAMLINFINE has a market capitalization of ₹3050 crores, placing it in the Small-cap category.
How volatile is CAMLINFINE stock?
CAMLINFINE has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for CAMLINFINE?
CAMLINFINE has a 52-week high of ₹N/A and low of ₹N/A.
What is CAMLINFINE's operating profit margin trend?
CAMLINFINE has a 5-year average Operating Profit Margin (OPM) of 12.80%, indicating the company's operational efficiency.
How is CAMLINFINE's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of 10.19% and YoY Profit Growth of -115.76%.
What is the institutional holding pattern in CAMLINFINE?
CAMLINFINE has FII holding of 2.11% and DII holding of 5.48%. Significant institutional holding often suggests professional confidence in the stock.